| 51 |
MINOPHAGEN C |
MONOAMMONIUM GLYCYRRHIZINATE 53 MG (AS GLYCYRRHIZIC ACID 40 MG), GLYCINE JP 400 MG, L-CYSTEINE HYDROCHLORIDE HYDRATE 22.29 MG (L-CYSTEINE HYDROCHLORIDE 20 MG) |
SOLUTION FOR INJECTION |
AMPOULES |
ECZEMA OR DERMATITIS, URTICARIA, PRURITUS, DRUG ERUPTION OR TOXICODERMA, STOMATITIS, INFANT STROPHULUS, PHLYCTEN. IMPROVEMENT OF ABNORMAL HEPATIC FUNCTION IN CHRONIC LIVER DISEASES. |
NULL |
AI KEN PHARMA CO., LTD |
MINOPHAGEN PHARMACEUTICAL CO.,LTD., ZAMA FACTORY |
JAPAN |
CERTIFICATE RELEASED |
02 I 5204/22 |
16-DEC-2024 |
15-DEC-2029 |
View |
| 52 |
MONTULAIR 10 |
MONTELUKAST SODIUM 10.4 MG EQ.TO MONTELUKAST 10 MG |
FILM-COATED TABLET |
ALU-ALU |
TREATMENT OF ASTHMA AS ADD-ON THERAPY IN THOSE PATIENT WITH MILD TO MODERATE PERSISTENT ASTHMA WHO ARE INADEQUATELY CONTROLLED ON INHALED CORTICOSTEROID, PROPHYLAXIS OF ASTHMA IN WHICH THE PREDOMINANT COMPONENT IS EXERCISE-INDUCED BRONCHOCONSTRICTION. |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO.,LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 4815/19 |
5-AUG-2022 |
4-AUG-2025 |
View |
| 53 |
MORIHEPAMIN |
EACH 200 ML CONTAINS: L-ISOLEUCINE 1.840 G, L-LEUCINE 1.890 G, L-LYSINE ACETATE 0.790 G, L-METHIONINE 0.088 G, L-PHENYLALANINE 0.060 G, L-THREONINE 0.428 G, L-TRYPTOPHAN 0.140 G, L-VALINE 1.780 G, L-ALANINE 1.680 G, L-ARGININE 3.074 G, L-ASPARTIC ACID 0.040 G, L-HISTI9DINE 0.620 G, L-PROLINE 1.060 G, L-SERINE 0.520 G, L-TYROSINE 0.080 G, GLYCINE 1.080 G |
SOLUTION FOR INFUSION |
PLASTIC BAG |
FOR SUPPORTIVE TREATMENT FOR HEPATIC ENCEPHALOPATHY SYNDROME IN PATIENTS WITH CHRONIC LIVER DISEASE |
NULL |
AI KEN PHARMA CO., LTD |
AY PHARMACEUTICALS CO.,LTD. SHIMIZU PLANT |
JAPAN |
CERTIFICATE RELEASED |
11 I 5331/22 |
1-DEC-2022 |
30-NOV-2025 |
View |
| 54 |
NERVICA 150 |
PREGABALIN 150 MG |
CAPSULE |
ALU-PVC |
FOR THE TREATMENT OF PERIPHERAL AND CENTRAL NEUROPATHIC PAIN IN ADULTS, AS ADJUNCTIVE THERAPY IN ADULTS WITH PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION, FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER IN ADULT |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 5289/22 |
14-Oct-2022 |
13-Oct-2025 |
View |
| 55 |
NERVICA 25 |
PREGABALIN 25 MG |
CAPSULE |
ALU-PVC |
FOR THE TREATMENT OF PERIPHERAL AND CENTRAL NEUROPATHIC PAIN IN ADULTS, AS ADJUNCTIVE THERAPY IN ADULTS WITH PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION, FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER IN ADULT |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 5290/22 |
14-Oct-2022 |
13-Oct-2025 |
View |
| 56 |
NERVICA 75 |
PREGABALIN 75 MG |
CAPSULE |
ALU-PVC/PVDC |
FOR THE TREATMENT OF PERIPHERAL AND CENTRAL NEUROPATHIC PAIN IN ADULTS, AS ADJUNCTIVE THERAPY IN ADULTS WITH PARTIAL SEIZURES WITH OR WITHOUT SECONDARY GENERALIZATION, FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER IN ADULT |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
10 I 5291/22 |
14-Oct-2022 |
13-Oct-2025 |
View |
| 57 |
OTAGIL 20 |
ROSUVASTATIN CALCIUM 20.834 MG EQ. TO ROSUVASTATIN 20 MG |
FILM COATED TABLET |
ALU-ALU |
TREATMENT OF HYPERCHOLESTEROLEMIA AND PREVENTION OF CARDIOVASCULAR EVENT |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
03 I 5428/23 |
31-Mar-2023 |
30-Mar-2026 |
View |
| 58 |
OTAGIL10 |
ROSUVASTATIN CALCIUM 10.417 MG EQ TO ROSUVASTATIN 10 MG |
FILM COATED TABLET |
ALU-ALU |
TREATMENT OF HYPERCHOLESTEROLEMIA AND PREVENTION OF CARDIOVASCULAR EVENT |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
03 I 5427/23 |
31-Mar-2023 |
30-Mar-2026 |
View |
| 59 |
PORMUS |
PARACETAMOL 500 MG, ORPHENADRINE CITRATE 35 MG |
TABLET |
ALU-ALU BLISTER |
TENSION HEADACHE, OCCIPITAL HEADACHE ASSOCIATED WITH SPASM OF SKELETAL MUSCLE IN REGION OF HEAD AND NECK. ACUTE AND TRAUMATIC CONDITIONS OF THE LIMS AND TRUNK. |
NULL |
AI KEN PHARMA CO., LTD |
UNISON LABORATORIES CO., LTD |
THAILAND |
CERTIFICATE RELEASED |
05 I 3350/09 |
19-Apr-2023 |
18-Apr-2026 |
View |
| 60 |
POSTINOR |
LEVONORGESTREL 0.75 MG |
TABLET |
ALU-PVC BLISTERPACK |
EMERGENCY CONTRACEPTION WITHIN 72 HOURS OF UNPROTECTED SEXUAL INTERCOURSE OR FAILURE OF A CONTRACEPTIVE METHOD |
NULL |
AI KEN PHARMA CO., LTD |
CHEMICAL WORKS OF GEDEON RICHTER PLC. |
HUNGARY |
CERTIFICATE RELEASED |
02 I 3814/13 |
26-SEP-2022 |
25-SEP-2025 |
View |
